---
title: "Weimob Delays Extraordinary General Meeting to Accommodate Holiday-Hit Shareholders"
description: "Weimob Inc. has postponed its extraordinary general meeting from February 25 to March 11, 2026, to accommodate shareholders affected by the Chinese New Year holidays. This decision aims to enhance sha"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276773218.md"
published_at: "2026-02-24T14:12:54.000Z"
---

# Weimob Delays Extraordinary General Meeting to Accommodate Holiday-Hit Shareholders

> Weimob Inc. has postponed its extraordinary general meeting from February 25 to March 11, 2026, to accommodate shareholders affected by the Chinese New Year holidays. This decision aims to enhance shareholder participation in the voting process. All resolutions will remain unchanged, and previously submitted proxy forms will still be valid. The current analyst rating for Weimob's stock (HK:2013) is a Hold, with a price target of HK$2.00. Weimob operates in the technology and digital services sector, focusing on solutions from its Shanghai headquarters.

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

An update from Weimob ( (HK:2013) ) is now available.

Weimob Inc. has postponed its first extraordinary general meeting of 2026 from February 25 to March 11 in Shanghai, after shareholders reported that the Chinese New Year holidays left them with limited time to vote. The company said the move is intended to better protect shareholder rights by allowing more investors to participate in the decision-making process.

All resolutions originally scheduled for the meeting will remain unchanged and will be tabled at the postponed session under the same record date and register-closure period. Previously submitted proxy forms will stay valid unless replaced, while shareholders who have not yet appointed proxies must submit their forms at least 48 hours before the new meeting time.

The most recent analyst rating on (HK:2013) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Weimob stock, see the HK:2013 Stock Forecast page.

**More about Weimob**

Weimob Inc. is a Hong Kong-listed company incorporated in the Cayman Islands that operates primarily in the technology and digital services sector. The group focuses on providing solutions from its Shanghai headquarters, serving shareholders in Mainland China and Hong Kong through its listed-share structure and corporate governance framework.

**Average Trading Volume:** 90,440,568

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$8.28B

Find detailed analytics on 2013 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [02013.HK - WEIMOB INC](https://longbridge.com/en/quote/02013.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 微盟集团根据一般授权完成了第二批次 A 类股份的配售 | 微盟集团已根据其一般授权完成了 172,123,000 股 2A 期认购股份的发行，每股价格为 2.26 港元，保持其公众持股比例超过 25%。此次配售是与 Infini Global Master Fund 进行的，属于公司多步骤融资策略 | [Link](https://longbridge.com/en/news/274835482.md) |
| “高市经济学” 对日元、日债及日股的影响 | 日本新任首相高市早苗推行财政扩张政策，赢得国会众议院绝对多数席位，可能对日元、日股及日本政府债券产生影响。她提议增加 21.3 万亿日元支出，暂停 8% 食品消费税，预计预算赤字将从 2.5% 扩大至 6%。日元在过去 14 年中贬值近 5 | [Link](https://longbridge.com/en/news/277134866.md) |
| 投资大佬德鲁肯米勒：我的优势不是智商，而是果断扣动扳机，卖飞英伟达 “肠子都悔青了” | 摩根士丹利《经验之谈》中，德鲁肯米勒认为其真正优势是 “扣动扳机” 的果断，以及从索罗斯学到的精髓：关键不在于对错，而在于对时赚多少、错时亏多少。他坦言 “逆向投资被高估”，认为群众 80% 的时间是对的，关键在于避开那 20% 的毁灭性时 | [Link](https://longbridge.com/en/news/277289579.md) |
| 渣打财报透视：息差见顶与 “轻资本财富中介” 的重构 | 渣打集团刚刚交出了一份强劲的成绩单。 在宏观经济逆风与全球降息周期的背景下，渣打不仅提前整整一年跨过… | [Link](https://longbridge.com/en/news/276703416.md) |
| 上一次美股出现这种情况，是在 2008 年 | 美股在 2023 年 2 月出现了与 2008 年相似的情况，个股与股指的脱钩程度达到前所未有的水平。尽管 AI 技术冲击各行业，美国经济数据依然坚挺，顺周期股票持续上涨。预计到年底，个股与指数之间的隐含波动率差将达到 18 个波动率点，这 | [Link](https://longbridge.com/en/news/277264031.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.